Cargando…
Biomarker development for translational geroscience: Considerations for a strategic framework focusing on early clinical development
Autor principal: | Sanders, Jason L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186596/ https://www.ncbi.nlm.nih.gov/pubmed/37024999 http://dx.doi.org/10.1111/acel.13837 |
Ejemplares similares
-
Aging Cell and the growing pains of translational geroscience
por: Montano, Monty
Publicado: (2023) -
BREAKING GROUND IN TRANSLATIONAL GEROSCIENCE: FROM BIOMARKERS TO CLINICAL TRIALS
por: Justice, Jamie
Publicado: (2022) -
INTEREST GROUP SESSION—GEROSCIENCE: METHODS FROM BENCH TO POPULATION SCIENCE TO INFORM CONSTRUCTION OF GEROSCIENCE CLINICAL TRIALS
por: Sanders, Jason L, et al.
Publicado: (2019) -
Global calling to develop geroscience research and promote healthy aging—Key discussion points from the International Geroscience Symposium in Shenzhen, China
por: Chen, Yiyin, et al.
Publicado: (2019) -
Challenges in developing Geroscience trials
por: Rolland, Yves, et al.
Publicado: (2023)